ロード中...
Rapamycin: Drug Repurposing in SARS-CoV-2 Infection
Since December 2019, SARS-CoV-2 (COVID-19) has been a worldwide pandemic with enormous consequences for human health and the world economy. Remdesivir is the only drug in the world that has been approved for the treating of COVID-19. This drug, as well as vaccination, still has uncertain effectivene...
保存先:
| 出版年: | Pharmaceuticals (Basel) |
|---|---|
| 主要な著者: | , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
MDPI
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8001969/ https://ncbi.nlm.nih.gov/pubmed/33807743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph14030217 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|